Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Net Cash Flow Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 198.34%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 467.41%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -14,223.53%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 453.08%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -125.22%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 53.46%
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn -415.04%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -415.04%
Dec 31, 2025 45.29%
Sep 30, 2025 23.26%
Jun 30, 2025 -42.09%
Mar 31, 2025 106.01%
Dec 31, 2024 1,879.07%
Sep 30, 2024 50.53%
Jun 30, 2024 189.06%
Mar 31, 2024 -608.67%
Dec 31, 2023 -68.50%
Sep 30, 2023 1,649.93%
Jun 30, 2023 334.12%
Mar 31, 2023 58.54%
Dec 31, 2022 123.25%
Sep 30, 2022 -87.23%
Jun 30, 2022 -1,316.09%
Mar 31, 2022 -3.08%
Dec 31, 2021 17.17%
Sep 30, 2021 -90.88%
Jun 30, 2021 104.89%
Mar 31, 2021 28.81%
Dec 31, 2020 44.98%
Sep 30, 2020 2,287.60%
Jun 30, 2020 -107.78%
Mar 31, 2020 7.13%
Dec 31, 2019 -39,866.67%
Sep 30, 2019 -489.86%
Jun 30, 2019 283.36%
Mar 31, 2019 -1,537.67%
Dec 31, 2018 101.27%
Sep 30, 2018 106.54%
Jun 30, 2018 7.66%
Mar 31, 2018 70.52%
Dec 31, 2017 -135.12%
Sep 30, 2017 -101.48%
Jun 30, 2017 91.22%
Mar 31, 2017 74.07%
Dec 31, 2016 212.56%
Sep 30, 2016 -321.08%
Jun 30, 2016 9,243.16%
Mar 31, 2016 -69.53%
Dec 31, 2015 -1,778.66%
Sep 30, 2015 -69.13%
Jun 30, 2015 97.48%
Mar 31, 2015 -644.66%
Dec 31, 2014 -101.76%
Sep 30, 2014 328.60%
Jun 30, 2014 -146.42%
Mar 31, 2014 -2.88%
Dec 31, 2013 4,480.31%
Sep 30, 2013 -62.38%
Jun 30, 2013 -317.80%
Mar 31, 2013 5.65%
Dec 31, 2012 -124.97%
Sep 30, 2012 608.26%
Jun 30, 2012 -161.73%
Mar 31, 2012 -240.54%